Cosmos Health Inc.

NasdaqCM:COSM Stock Report

Market Cap: US$12.1m

Cosmos Health Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:COSM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
24 Apr 25BuyUS$71,000Grigorios SiokasIndividual177,234US$0.40
24 Apr 25BuyUS$102,000Grigorios SiokasIndividual254,618US$0.40
23 Apr 25BuyUS$82,000Grigorios SiokasIndividual205,000US$0.40
22 Apr 25BuyUS$63,000Grigorios SiokasIndividual175,000US$0.36
21 Apr 25BuyUS$208,000Grigorios SiokasIndividual654,912US$0.32
04 Mar 25BuyUS$45,000Grigorios SiokasIndividual85,714US$0.53
03 Mar 25BuyUS$65,000Grigorios SiokasIndividual132,572US$0.49
24 Feb 25BuyUS$200,000Grigorios SiokasIndividual354,296US$0.56
30 Jan 25BuyUS$34,000Grigorios SiokasIndividual51,414US$0.66
22 Jan 25BuyUS$30,000Grigorios SiokasIndividual38,900US$0.77
17 Jan 25BuyUS$25,000Grigorios SiokasIndividual29,158US$0.86
16 Jan 25BuyUS$40,000Grigorios SiokasIndividual47,904US$0.83
15 Jan 25BuyUS$50,000Grigorios SiokasIndividual62,500US$0.80
14 Jan 25BuyUS$60,000Grigorios SiokasIndividual87,247US$0.69
13 Jan 25BuyUS$100,000Grigorios SiokasIndividual163,666US$0.61
20 Dec 24BuyUS$150,000Grigorios SiokasIndividual257,334US$0.58
20 Dec 24BuyUS$50,000Georgios TerzisIndividual85,778US$0.58
01 Nov 24SellUS$5John HoidasIndividual5,000US$0.001

Insider Trading Volume

Insider Buying: COSM insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of COSM?
Owner TypeNumber of SharesOwnership Percentage
Institutions871,5853.2%
Hedge Funds2,508,0139.22%
Individual Insiders8,360,10230.7%
General Public15,458,46156.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 61.5%.

Top Shareholders

Top 25 shareholders own 43.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.5%
Grigorios Siokas
5,582,066US$2.5m82.3%no data
9.22%
Armistice Capital LLC
2,508,013US$1.1m16.8%0.03%
6.92%
Andreas Bovopoulos
1,880,773US$835.1k0%no data
2.67%
Georgios Terzis
727,263US$322.9k0%no data
0.98%
BlackRock, Inc.
267,797US$118.9k0%no data
0.71%
Geode Capital Management, LLC
193,432US$85.9k29.2%no data
0.5%
The Vanguard Group, Inc.
134,834US$59.9k0%no data
0.26%
UBS Asset Management AG
71,516US$31.8k-38.2%no data
0.17%
Nikolaos Bardakis
45,000US$20.0k0%no data
0.16%
Susquehanna International Group, LLP, Asset Management Arm
42,272US$18.8k0%no data
0.15%
Anastasios Aslidis
40,000US$17.8k0%no data
0.12%
XTX Holdings Limited, Asset Management Arm
32,617US$14.5k0%no data
0.11%
Suhel Bhutawala
30,000US$13.3k0%no data
0.11%
Virtu Financial LLC, Asset Management Arm
29,787US$13.2k0%no data
0.091%
State Street Global Advisors, Inc.
24,743US$11.0k0%no data
0.087%
Two Sigma Securities, LLC, Asset Management Arm
23,544US$10.5k63.7%no data
0.081%
Hudson River Trading LLC, Asset Management Arm
21,929US$9.7k0%no data
0.076%
Northern Trust Global Investments
20,554US$9.1k0%no data
0.074%
Manfred Ziegler
20,000US$8.9k0%no data
0.074%
Demetrios Demetriades
20,000US$8.9k0%no data
0.055%
John Hoidas
15,000US$6.7k-25%no data
0.014%
Tower Research Capital Europe Limited
3,726US$1.7k-2.61%no data
0.011%
Group One Trading LP, Asset Management Arm
2,884US$1.3k89%no data
0.0052%
Simplex Trading, LLC, Asset Management Arm
1,418US$629.254.3%no data
0.00074%
Cornerstone Planning Group Inc.
200US$89.40%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/07 04:46
End of Day Share Price 2025/05/07 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cosmos Health Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Howard HalpernTaglich Brothers, Inc.